000			02021 a2200589 4500
005			20250517232053.0
264		0	_c20191114
008			201911s 0 0 eng d
022			_a2152-2669
024	7		_a10.1016/j.clml.2018.06.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aPerry, Marielle
245	0	0	_aFLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia. _h[electronic resource]
260			_bClinical lymphoma, myeloma & leukemia _c12 2018
300			_ae545-e550 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiomarkers, Tumor
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytogenetic Analysis
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xmethods
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLeukemia, Myeloid, Acute _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aNucleophosmin
650	0	4	_aPrognosis
650	0	4	_aProtein Interaction Domains and Motifs _xgenetics
650	0	4	_aRetrospective Studies
650	0	4	_aTandem Repeat Sequences
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
650	0	4	_afms-Like Tyrosine Kinase 3 _xantagonists & inhibitors
700	1		_aBertoli, Sarah
700	1		_aRocher, Clément
700	1		_aHayette, Sandrine
700	1		_aDucastelle, Sophie
700	1		_aBarraco, Fiorenza
700	1		_aLabussière-Wallet, Hélène
700	1		_aSalles, Gilles
700	1		_aRecher, Christian
700	1		_aThomas, Xavier
700	1		_aPaubelle, Etienne
773	0		_tClinical lymphoma, myeloma & leukemia _gvol. 18 _gno. 12 _gp. e545-e550
856	4	0	_uhttps://doi.org/10.1016/j.clml.2018.06.006 _zAvailable from publisher's website
999			_c28705021 _d28705021